Jing Ding

1.1k total citations
37 papers, 844 citations indexed

About

Jing Ding is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jing Ding has authored 37 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Jing Ding's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Jing Ding is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Jing Ding collaborates with scholars based in China, Germany and United States. Jing Ding's co-authors include Wei‐Hao Sun, Huae Xu, Xiaolin Li, Hao Zhang, Jiyan Liu, Yang Du, Hong Shang, Jiyan Liu, Hui Yang and Zhibo Hou and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Hepatology.

In The Last Decade

Jing Ding

36 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jing Ding China	15	588	337	105	76	72	37	844
Man Zhu China	17	519 0.9×	336 1.0×	132 1.3×	77 1.0×	64 0.9×	54	891
Neda Shajari Iran	10	616 1.0×	255 0.8×	148 1.4×	89 1.2×	90 1.3×	14	833
Anuradha Kirtonia India	10	563 1.0×	284 0.8×	173 1.6×	47 0.6×	106 1.5×	12	904
Shu‐Qiang Weng China	17	631 1.1×	346 1.0×	138 1.3×	53 0.7×	97 1.3×	36	949
Fanhua Kong China	16	445 0.8×	255 0.8×	130 1.2×	45 0.6×	119 1.7×	40	786
Bo Lin China	16	521 0.9×	248 0.7×	183 1.7×	53 0.7×	67 0.9×	52	906
İlhan Yaylım Türkiye	17	395 0.7×	160 0.5×	144 1.4×	64 0.8×	60 0.8×	76	798
Feiyu Chen China	20	731 1.2×	493 1.5×	163 1.6×	54 0.7×	85 1.2×	37	1.1k
Kui Sheng Chen China	2	606 1.0×	241 0.7×	216 2.1×	99 1.3×	144 2.0×	5	1.0k

Countries citing papers authored by Jing Ding

Since Specialization

Citations

This map shows the geographic impact of Jing Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Ding more than expected).

Fields of papers citing papers by Jing Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Ding. The network helps show where Jing Ding may publish in the future.

Co-authorship network of co-authors of Jing Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Ding. A scholar is included among the top collaborators of Jing Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Ding. Jing Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gong, Li, Ruirui Yang, Huanhuan Cui, et al.. (2025). The impact of short-term comprehensive treatment on cardiovascular-kidney-metabolic syndrome and its components in patients with type 2 diabetes. Frontiers in Endocrinology. 16. 1659340–1659340.

Ding, Jing, et al.. (2022). Current understanding on long non-coding RNAs in immune response to COVID-19. Virus Research. 323. 198956–198956. 11 indexed citations

Meng, Fanling, Jing Ding, Wei Xu, et al.. (2022). Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway. Translational Cancer Research. 11(2). 414–425. 7 indexed citations

Liu, Bin, Li Zeng, Jing Ding, et al.. (2021). Potential predictive value of plasma heat shock protein 90α in lung cancer. Journal of International Medical Research. 49(12). 3619125321–3619125321. 7 indexed citations

Wang, Ying, et al.. (2021). MiR-200c-3p aggravates gastric cell carcinoma via KLF6. Genes & Genomics. 43(11). 1307–1316. 10 indexed citations

Zhang, Long, Wei Ding, Zhiqiang Shi, et al.. (2020). Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes. Genomics. 113(1). 1166–1175. 30 indexed citations

Ding, Jing, Xiaoyan Cheng, Shuang Liu, et al.. (2019). Apatinib exerts anti-tumour effects on ovarian cancer cells. Gynecologic Oncology. 153(1). 165–174. 23 indexed citations

Liu, Shuang, Lin Mu, Jing Ding, et al.. (2019). RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma. Diagnostic Pathology. 14(1). 7–7. 11 indexed citations

Ding, Jing, Yueting Zhu, Lie Yang, et al.. (2018). 14-3-3zeta is involved in the anticancer effect of metformin in colorectal carcinoma. Carcinogenesis. 39(3). 493–502. 5 indexed citations

10.

Chen, Ye, Yuntao Li, Jing Ding, et al.. (2018). Selected proliferation markers correlated with dynamics of growth in colorectal cancer. European Journal of Cancer Prevention. 28(3). 181–187. 1 indexed citations

11.

Zhou, Yi, et al.. (2016). The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells. Tumor Biology. 37(7). 8555–8566. 44 indexed citations

12.

Ding, Jing, Cong Li, Jie Tang, et al.. (2016). Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus. Pathology & Oncology Research. 22(4). 773–779. 14 indexed citations

13.

Yang, Yu, Yang Du, Cong Li, et al.. (2015). Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy. Cancer Chemotherapy and Pharmacology. 75(4). 783–790. 11 indexed citations

14.

Ding, Jing, et al.. (2015). The expression difference of insulin-like growth factor 1 receptor in breast cancers with or without diabetes. Journal of Cancer Research and Therapeutics. 11(2). 295–295. 8 indexed citations

15.

Zhang, Hao, Jing Ding, Huae Xu, et al.. (2013). Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer. Phytomedicine. 21(3). 348–355. 56 indexed citations

16.

Ding, Jing, Jie Tang, Xin Chen, et al.. (2013). Expression Characteristics of Proteins of the Insulin-like Growth Factor Axis in Non-small Cell Lung Cancer Patients with Preexisting Type 2 Diabetes Mellitus. Asian Pacific Journal of Cancer Prevention. 14(10). 5675–5680. 18 indexed citations

17.

Li, Longhao, Dong Hang, Feng Zhao, et al.. (2013). The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil. European Journal of Cancer. 49(7). 1752–1760. 30 indexed citations

18.

Zhang, Hao, Xiaolin Li, Jing Ding, et al.. (2012). Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). International Journal of Pharmaceutics. 441(1-2). 261–268. 93 indexed citations

19.

Ding, Jing & Jingli Liu. (2011). Efficacy Observation of Yaotongning Capsule in the Treatment of Lumbar Disc Herniation. Zhongguo yaofang. 1 indexed citations

20.

Shen, Juan, Xuemei Lu, Xiaobao Jin, et al.. (2011). Expression of a novel dual-functional protein – The antimicrobial peptide LL-37 fused with human acidic fibroblast growth factor in Escherichia coli. Protein Expression and Purification. 81(1). 119–125. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact